Drug Type Small molecule drug |
Synonyms CHF 6523 |
Target |
Mechanism Phosphatidylinositol 3-kinase family inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | GB | 21 Jul 2020 | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | GB | 24 Jul 2019 |